| Literature DB >> 27562190 |
Takanori Honda1,2,3, Sanmei Chen1, Koji Yonemoto4, Hiro Kishimoto2, Tao Chen1, Kenji Narazaki5, Yuka Haeuchi1, Shuzo Kumagai6,7.
Abstract
BACKGROUND: This study aimed to examine the associations between time spent in prolonged and non-prolonged sedentary bouts and the development of metabolic syndrome.Entities:
Keywords: Accelerometry; Central obesity; Epidemiology; Metabolic syndrome; Physical activity; Sedentary lifestyle
Mesh:
Year: 2016 PMID: 27562190 PMCID: PMC5000401 DOI: 10.1186/s12889-016-3570-3
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Sample characteristics by quartiles of time spent in prolonged sedentary bouts (≥30 min), the Ryobi Health Survey 2009 – 2010 (n = 430)
| Characteristics | Time spent in prolonged sedentary boutsa |
| |||||||
|---|---|---|---|---|---|---|---|---|---|
| Q1 ( | Q2 ( | Q3 ( | Q4 ( | ||||||
| Age group, % (n) | <0.001 | ||||||||
| 40–49 | 48.6 | (52) | 45.4 | (49) | 62.6 | (67) | 76.9 | (83) | |
| 50–59 | 40.2 | (43) | 41.7 | (45) | 28.0 | (30) | 20.4 | (22) | |
| 60–64 | 11.2 | (12) | 13.0 | (14) | 9.3 | (10) | 2.8 | (3) | |
| Women, % (n) | 13.1 | (14) | 13.9 | (15) | 13.1 | (14) | 13.9 | (15) | 0.9130 |
| Education, college or university level, % (n) | 36.4 | (39) | 57.4 | (62) | 72.0 | (77) | 73.1 | (79) | <0.001 |
| Current smoker, % (n) | 36.4 | (39) | 38.9 | (42) | 29.0 | (31) | 25.0 | (27) | 0.028 |
| Family income (JPY), % (n) | 0.028 | ||||||||
| < 4 million | 19.6 | (21) | 20.4 | (22) | 5.6 | (6) | 2.8 | (3) | |
| 4–8 million | 57.9 | (62) | 49.1 | (53) | 65.4 | (70) | 74.1 | (80) | |
| 8+ million | 22.4 | (24) | 30.6 | (33) | 29.0 | (31) | 23.1 | (25) | |
| Moderate-to-vigorous physical activity, min/wk, median (interquartile range) | 50 | (11, 141) | 66 | (23, 168) | 57 | (11, 151) | 41 | (11, 174) | 0.564 |
| Device wear-time, min/d, median (interquartile range) | 850 | (785, 916) | 843 | (790, 922) | 834 | (787, 912) | 865 | (776, 929) | 0.7503 |
| Central obesity, % (n) | 14.0 | (15) | 11.1 | (12) | 13.1 | (14) | 11.1 | (12) | 0.635 |
| Elevated blood pressure, % (n) | 29.0 | (31) | 33.3 | (36) | 28.0 | (30) | 32.4 | (35) | 0.801 |
| Hypertriglyceridemia, % (n) | 10.3 | (11) | 18.5 | (20) | 16.8 | (18) | 24.1 | (26) | 0.015 |
| Low HDL-cholesterol level, % (n) | 1.9 | (2) | 2.8 | (3) | 4.7 | (5) | 1.9 | (2) | 0.799 |
| Hyperglycemia, % (n) | 40.2 | (43) | 35.2 | (38) | 32.7 | (35) | 25.9 | (28) | 0.026 |
| Number of affected components, % (n)b | 0.878 | ||||||||
| Zero | 30.8 | (33) | 29.6 | (32) | 33.6 | (36) | 27.8 | (30) | |
| One | 43.0 | (46) | 39.8 | (43) | 37.4 | (40) | 49.1 | (53) | |
| Two | 26.2 | (28) | 30.6 | (33) | 29.0 | (31) | 23.1 | (25) | |
Data are presented as a median (interquartile range) or % (n). HDL-cholesterol, high-density lipoprotein cholesterol
aTime spent in prolonged sedentary time was adjusted for time spent wearing the device using the residual method prior to classifying into sex-specific quartiles (Q1 – Q4). Cut-offs for quartiles were 106.7, 165.5, and 269.2 min/day for men, and 65.1, 122.7, and 195.4 for women for those who wore the accelerometer device for the average amount of wear-time
bNumber of components of metabolic syndrome at baseline survey
Multivariable-adjusted hazard ratios (95 % confidence intervals) for the development of metabolic syndrome, the Ryobi Health Survey 2009 – 2010 (n = 430)
| Cases (n) | Incident rate (per 1000 person-years) | Model 1 | Model 2 | Model 3 | Model 4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HR | 95 % CI |
| HR | 95 % CI |
| HR | 95 % CI |
| HR | 95 % CI |
| |||
| Total sedentary time (≥1-min bout) | ||||||||||||||
| Q1 | 22 | 62.5 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||||
| Q2 | 23 | 68.0 | 1.23 | (0.63 – 2.39) | 0.542 | 1.39 | (0.67 – 2.86) | 0.376 | 1.37 | (0.66 – 2.82) | 0.398 | 1.50 | (0.73 – 3.09) | 0.272 |
| Q3 | 20 | 63.3 | 1.66 | (0.88 – 3.13) | 0.116 | 1.87 | (0.94 – 3.72) | 0.075 | 1.84 | (0.92 – 3.68) | 0.083 | 1.76 | (0.87 – 3.55) | 0.118 |
| Q4 | 18 | 56.6 | 1.12 | (0.56 – 2.21) | 0.752 | 1.30 | (0.61 – 2.76) | 0.500 | 1.26 | (0.59 – 2.69) | 0.559 | 1.55 | (0.70 – 3.43) | 0.278 |
| Non-prolonged sedentary time (<30-min bout) | ||||||||||||||
| Q1 | 16 | 52.6 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||||
| Q2 | 18 | 55.9 | 0.71 | (0.38 – 1.31) | 0.268 | 0.72 | (0.39 – 1.34) | 0.298 | 0.71 | (0.38 – 1.33) | 0.287 | 0.79 | (0.42 – 1.48) | 0.465 |
| Q3 | 27 | 81.3 | 0.82 | (0.45 – 1.48) | 0.500 | 0.82 | (0.45 – 1.51) | 0.520 | 0.81 | (0.44 – 1.49) | 0.491 | 1.09 | (0.59 – 2.03) | 0.785 |
| Q4 | 22 | 60.1 | 0.85 | (0.47 – 1.52) | 0.573 | 0.85 | (0.47 – 1.56) | 0.606 | 0.83 | (0.45 – 1.52) | 0.546 | 1.08 | (0.57 – 2.02) | 0.817 |
| Prolonged sedentary time (≥30-min bout) | ||||||||||||||
| Q1 | 20 | 58.3 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||||
| Q2 | 23 | 70.6 | 2.58 | (1.24 – 5.37) | 0.011 | 2.71 | (1.29 – 5.68) | 0.009 | 2.72 | (1.30 – 5.73) | 0.008 | 3.03 | (1.42 – 6.49) | 0.004 |
| Q3 | 21 | 64.4 | 2.16 | (1.02 – 4.59) | 0.045 | 2.41 | (1.11 – 5.25) | 0.026 | 2.42 | (1.11 – 5.25) | 0.026 | 2.25 | (1.03 – 4.92) | 0.040 |
| Q4 | 19 | 57.8 | 2.49 | (1.18 – 5.24) | 0.017 | 2.86 | (1.31 – 6.21) | 0.008 | 2.85 | (1.31 – 6.18) | 0.008 | 2.90 | (1.30 – 6.44) | 0.009 |
HR hazard ratio, CI confidence interval. Sedentary variables were adjusted for time spent wearing the device using the residual method prior to classifying into sex-specific quartiles. Model 1 was adjusted for sex and age. Model 2 was adjusted for sex, age, education, smoking, and family income. Model 3 was additionally adjusted for moderate-to-vigorous physical activity. Model 4 was additionally adjusted for waist circumference. Cut-offs for quartiles were 106.7, 165.5, and 269.2 min/day for men, and 65.1, 122.7, and 195.4 for women among those who wore the accelerometer device for the average amount of wear-time
Fig. 1Associations of time spent in prolonged sedentary bouts with metabolic syndrome according to the number of metabolic syndrome components at baseline. Panel a, Participants who at baseline had zero or one affected component. The numbers of participants in each group were 79, 75, 76, and 83 for Q1 to Q4 in panel A, respectively. Panel b, Participants with two affected components at baseline. The numbers of participants in each group were 28, 33, 31, and 25 for Q1 to Q4 in panel B, respectively. *p < 0.05